Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Clinical trial NCT06491446 · COMPLETED

Trial details

NCT number: NCT06491446
Sponsor: Antiva Biosciences
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Papillomavirus Infection

Start date: 2024-03-27
Primary completion: 2025-10-17
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.